These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 33794325)
1. Sequential receptor-mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment. Shen J; Sun C; Wang Z; Chu Z; Liu C; Xu X; Xia M; Zhao M; Wang C Int J Pharm; 2021 May; 601():120553. PubMed ID: 33794325 [TBL] [Abstract][Full Text] [Related]
2. Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer. Wang Z; Sun C; Wu H; Xie J; Zhang T; Li Y; Xu X; Wang P; Wang C Mater Today Bio; 2022 Jan; 13():100189. PubMed ID: 34977528 [TBL] [Abstract][Full Text] [Related]
3. [Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti-tumor Effects]. Yu M; Zhao M; Yu R; Chu S; Xu J; Xia M; Wang C J Control Release; 2019 Jun; 304():242-258. PubMed ID: 31071376 [TBL] [Abstract][Full Text] [Related]
4. Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy. Lee S; Lee Y; Kim H; Lee DY; Jon S Biomacromolecules; 2018 Jun; 19(6):2270-2277. PubMed ID: 29712433 [TBL] [Abstract][Full Text] [Related]
5. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy. Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594 [TBL] [Abstract][Full Text] [Related]
6. A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway. Zhang H; Liu X; Wu F; Qin F; Feng P; Xu T; Li X; Yang L Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196894 [TBL] [Abstract][Full Text] [Related]
7. Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy. Wang Y; Wang Z; Chen B; Yin Q; Pan M; Xia H; Zhang B; Yan Y; Jiang Z; Zhang Q; Wang Y Nano Lett; 2021 May; 21(10):4371-4380. PubMed ID: 33984236 [TBL] [Abstract][Full Text] [Related]
8. Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes. Li X; Yang W; Zou Y; Meng F; Deng C; Zhong Z J Control Release; 2015 Dec; 220(Pt B):704-14. PubMed ID: 26348387 [TBL] [Abstract][Full Text] [Related]
9. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy. Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466 [TBL] [Abstract][Full Text] [Related]
10. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer. Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335 [TBL] [Abstract][Full Text] [Related]
11. Prodrug-Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death. Bai S; Yang LL; Wang Y; Zhang T; Fu L; Yang S; Wan S; Wang S; Jia D; Li B; Xue P; Kang Y; Sun ZJ; Xu Z Small; 2020 May; 16(19):e2000214. PubMed ID: 32309900 [TBL] [Abstract][Full Text] [Related]
12. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells. Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023 [TBL] [Abstract][Full Text] [Related]
13. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction. Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192 [TBL] [Abstract][Full Text] [Related]
14. Glutathione-sensitive mesoporous nanoparticles loaded with cinnamaldehyde for chemodynamic and immunological therapy of cancer. Zhu L; Li W; Liu C; Yue S; Qiao Y; Cui Y; Cheng J; Zhang M; Zhang P; Zhang B; Hou Y J Mater Chem B; 2023 Sep; 11(36):8717-8731. PubMed ID: 37646819 [TBL] [Abstract][Full Text] [Related]
15. Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy. Jiang H; Fu H; Guo Y; Hu P; Shi J Biomaterials; 2022 Oct; 289():121799. PubMed ID: 36152515 [TBL] [Abstract][Full Text] [Related]
16. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. Banstola A; Poudel K; Kim JO; Jeong JH; Yook S J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800 [TBL] [Abstract][Full Text] [Related]
18. Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death. Tu K; Deng H; Kong L; Wang Y; Yang T; Hu Q; Hu M; Yang C; Zhang Z ACS Appl Mater Interfaces; 2020 Apr; 12(14):16018-16030. PubMed ID: 32192326 [TBL] [Abstract][Full Text] [Related]
19. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle. Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547 [TBL] [Abstract][Full Text] [Related]
20. A Cascade-Targeted Enzyme-Instructed Peptide Self-Assembly Strategy for Cancer Immunotherapy through Boosting Immunogenic Cell Death. Xie L; Ding Y; Zhang X; Zhang Z; Zeng S; Wang L; Yang Z; Liu Q; Hu ZW Small Methods; 2023 May; 7(5):e2201416. PubMed ID: 36965100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]